Pharma

The latest news on ARTiFACTS Verify

Posted on

It’s been a little while since we’ve given you an update on what’s happening with ARTiFACTS Verify – and that’s because it’s been all hands on deck building on our successful pilot and scaling up our platform. We’ve got a lot to tell you so keep an eye on the blog over the coming weeks. …

Pharma

Challenges Of Supply Vs Demand In The US Pharmaceutical Supply Chain

Posted on
Three pills on dark grey background highlighted by natural light

The United States faces numerous challenges when it comes to balancing supply v demand in the pharmaceutical supply chain. The intricate nature of the pharmaceutical industry, coupled with the country’s diverse healthcare system, regulatory framework, and evolving market dynamics, contribute to a complex landscape that presents both opportunities and limitations. Here, we will explore some…

Pharma

The cost of substandard or falsified chemotherapy drugs in LMICs – and what we’re doing to help

Posted on

Cancer is one of the leading causes of death worldwide, and the use of chemotherapy drugs is a critical component of cancer treatment. Unfortunately, in many low and middle-income countries (LMICs), the availability of high-quality, effective chemotherapy medicine is limited due to the prevalence of substandard or falsified drugs. These drugs not only fail to…

Pharma

How the ARTiFACTS and Notre Dame collaboration addresses substandard or falsified drugs in pharmaceutical supply chains, a global public health challenge

Posted on

Today, virtually every country is impacted by substandard or falsified drugs entering their system, from generics to more expensive treatments for cancer and pain management. And the full extent of this problem is not known – but the WHO conservatively estimates that 200 million people are affected.   Up to 2 billion people around the world…